UK Government's infatuation with gene therapy goes back a long way—it's not healthy

Government celebrations

Late last month I posted on how UK Government celebrated a £7.1 million funding award for Oxford Biomedica (OXB), a contract development and manufacturing organisation (CDMO) in gene therapy. As the consultant commissioned to help frame the application for the funding call, titled: Advanced Manufacturing Supply Chain Initiative (A…